Description

I am a former Vice President, Programs & Portfolio Office, with over 20 years of leadership experience in biotech and pharmaceutical environments.

Today, I operate as a Fractional Chief of Staff and Portfolio & Governance Executive, partnering with biotech CEOs, founders and Boards at critical inflection points.

I step in when:

• Portfolio complexity outpaces structure

• Capital discipline becomes decisive

• Execution credibility must be restored

My role is to bring executive alignment, governance clarity and milestone-driven prioritisation without adding bureaucracy.

I operate as an embedded executive partner, not an external consultant.

Languages

French
Native or bilingual
English
Native or bilingual
German
Conversational
Spanish
Conversational

Workplace preferences

Can work on-site

Bâle (up to 50km)

enAbel Consulting
Founder & Fractional Executive
BIOTECH
June 2025 - Today (1 year)
Bâle, Switzerland
Independent executive advisory platform supporting biotech leadership teams in governance structuring, portfolio prioritization and executive execution alignment.

Selected Mandate:
Synendos Therapeutics (CH)
Head of Development (Fractional Executive Mandate – 6 months)
• Acted as executive integrator between CEO, CMO, CCO and development teams
• Provided strategic development oversight during critical corporate phase
• Structured decision frameworks and cross-functional alignment mechanisms
• Reinforced portfolio focus and milestone discipline in capital-sensitive context
• Ensured executive visibility across development priorities and resource allocation
Fractional Leadership Biotechnology Program Leadership Portfolio Strategy Strategic Planning & Execution
MindMed (now Definium Therapeutics) - Biotech (US/CH)
VP, Head of Programs and Portfolio Office
BIOTECH
September 2020 - May 2025 (4 years and 8 months)
Zoug, Switzerland
Former executive leader responsible for portfolio governance, cross-functional execution alignment and milestone-driven delivery in a fast-scaling biotech environment.

Reported to Executive Leadership and worked closely with Board-level stakeholders during critical growth and capital allocation phases.

Scope of responsibility:
• Built and led the Programs & Portfolio Office
• Designed portfolio governance and decision frameworks
• Established milestone-driven prioritisation across clinical programs
• Strengthened executive-level risk visibility and escalation mechanisms
• Aligned cross-functional teams (Clinical, Regulatory, CMC, Finance) around strategic development milestones

Strategic impact:
• Increased execution predictability across pipeline programs
• Reduced decision latency at the executive level
• Improved portfolio transparency under capital pressure
• Enhanced cross-functional accountability and milestone discipline
Executive Leadership Portfolio Strategy Portfolio Governance Cross-functional Team Leadership Organizational Design
Creso Pharma – Biotech
Head of Operations
BIOTECH
September 2017 - August 2020 (2 years and 11 months)
Zug, Switzerland
Senior operating executive partnering directly with the CEO during a high-growth and corporate structuring phase.

Responsible for strengthening operational foundations, governance maturity and executive-level coordination across functions.

Scope of responsibility:
• Oversaw corporate operations across finance, administration, and external partnerships
• Contributed to corporate finance structuring and due diligence processes
• Supported M&A activities and cross-border growth initiatives
• Strengthened governance processes and executive reporting
• Drove operational alignment between leadership, external advisors, and investors

Strategic impact:
• Increased operational discipline and transparency
• Improved executive decision support during the expansion phase
• Enhanced cross-functional coordination and scalability
Executive Leadership Operational Strategy Corporate Governance Corporate Finance Mergers & Acquisitions